Vancomycin hydrochloride
Inquiry
| Post Date: | Mar 06,2015 |
| Expiry Date: | Sep 02,2015 |
| Detailed Description: |
Cas No. :1404-93-9
Quantity: 1Kilograms Price:1 USD Metric Tons Vancomycin hydrochloride Synonym: vancocinehydrochloride;LYPHOCIN;VANCOMYCIN, HYDROCHLORIDE, STREPTOMYCES ORIENTALIS;VANCOR;VANCOCIN;VANCOCIN HYDROCHLORIDE;VANCOMYCIN HCL;VANCOMYCIN HCL, STREPTOMYCES ORIENTALIS CAS: 1404-93-9 MF: C66H76Cl3N9O24 MW: 1485.71 EINECS: 215-772-6 Assay: 99% Appearance: white powder Specification: CP HS: 2941909000 Property: Vancomycin is a glycopeptide antibiotic, vancomycin hydrochloride, at room temperature for white or white crystalline powder, its mechanism of action is with high affinity to the alanyl alanine sensitive bacterial cell wall peptidoglycan precursors at the end of the block polymer, composed of peptidoglycan synthesis of bacterial cell wall, resulting in killing bacteria defect of cell wall. Usage: 1. pairs of strong bactericidal effect of gram positive bacteria, has strong antibacterial activity against Staphylococcus aureus, Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, etc.; 2. on the anaerobic streptococci, Clostridium difficile, anthrax bacillus, actinomyces, Diphtheria Bacillus, gonococcus, Streptococcus viridans, Streptococcus bovis, Enterococcus faecalis, also has certain antibacterial effect. 3. for most gram negative bacteria, Mycobacterium, Rickettsia, chlamydia or fungi are invalid. Clinically applied to treatment by Meticillin resistant Staphylococcus aureus and other bacteria infection: septicemia, endocarditis, arthritis, osteomyelitis, burns, trauma and operation of superficial infection, pneumonia, lung abscess, empyema, peritonitis, meningitis, pseudomembranous colitis, skin and soft tissue infection etc.. Penicillin allergy of enterococcal endocarditis, Corynebacterium (diphtheroid Bacillus) drug of first choice for treatment of endocarditis. Package: 25kg/drum |
| CAS Registry Number: | 1404-93-9 |
| Synonyms: | ;(3S-(3R*,6S*(S*),7S*,22S*,23R*,26R*,36S*,38aS*))-3-(2-Amino-2-oxoethyl)-44-((2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl)oxy)-10,19-dichloro-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32-pentahydroxy-6-((4-methyl-2-(methylamino)-1-oxopentyl)amino)-2,5,24,38,39-pentaoxo-22H-8,11:18,21-dietheno-23,36-(iminomethano)-13,16:31,35-dimetheno-1H,16H-(1,6,9)oxadiazacyclohexadecino(4,5-m)(10,2,16)benzoxadiazacyclotetracosine-26-carboxylic acid, monohydrochloride;Vancomycin HCl;Vancomycin monohydrochloride;Vancor;UNII-71WO621TJD;Vancocine hydrochloride;Vancocin hydrochloride;48-({3-[(4-amino-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl}oxy)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-{[4-methyl-2-(methylamino)pentanoyl]amino}-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2~3,6~.2~14,17~.1~8,12~.1~29,33~.0~10,25~.0~34,39~]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid hydrochloride (1:1) (non-preferred name);(1S,2R,18R,19R,22S,25R,28R,40S)-48-{[(2S,3R,4S,5S,6R)-3-{[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-{[(2R)-4-methyl-2-(methylamino)pentanoyl]amino}-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2~3,6~.2~14,17~.1~8,12~.1~29,33~.0~10,25~.0~34,39~]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid (non-preferred name);(1S,2R,18R,19R,22S,25R,28R,40S)-48-{[(2S,3R,4S,5S,6R)-3-{[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-{[(2R)-4-methyl-2-(methylamino)pentanoyl]amino}-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid hydrochloride (non-preferred name); |
| Molecular Formula: | C66H76Cl3N9O24 |
| Molecular Weight: | 1485.7145 |
| Molecular Structure: | 
|
| Hazard Symbols: |  Xi:Irritant; |
| Risk Codes: | R43:; |
| Safety Description: | S24/25:; |
| Company: | Hubei Yuancheng Pharmaceutical Co.,Ltd [ China ] |
| Contact: | Kelly |
| Tel: | +86-27-50755978 |
| Fax: | +86-27-68886696 |
| Email: | yckelly@yccreate.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
